MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 21, 2002--C. R. Bard,
Inc. (NYSE-BCR) today reiterated that its process for electing a
successor to Chairman and CEO, William H. Longfield, is not expected
to be completed until the spring of 2003.
The company said that a recent media report anticipating the
outcome of this process is without basis.
C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill,
New Jersey, is a leading multinational developer, manufacturer and
marketer of health care products in the fields of vascular, urology,
oncology and surgical specialty products.
C.R. Bard, Inc.
Todd C. Schermerhorn, 908/277-8139
Holly P. Glass, 703/754-2848